blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4169539

EP4169539 - SILK-HYALURONIC ACID BASED TISSUE FILLERS AND METHODS OF USING THE SAME [Right-click to bookmark this link]
StatusGrant of patent is intended
Status updated on  13.08.2024
Database last updated on 11.09.2024
FormerExamination is in progress
Status updated on  11.04.2024
FormerRequest for examination was made
Status updated on  27.10.2023
FormerThe application has been published
Status updated on  24.03.2023
Most recent event   Tooltip13.08.2024New entry: Communication of intention to grant a patent 
Applicant(s)For all designated states
Evolved by Nature, Inc.
196 Boston Avenue
Medford, MA 02155 / US
[2023/17]
Inventor(s)01 / ALTMAN, Gregory H.
Providence, RI, 02906 / US
02 / XU, Peng
Lexington, MA, 02421 / US
03 / JIN, Erlei
Peabody, MA, 01960 / US
 [2023/17]
Representative(s)Maiwald GmbH
Elisenhof
Elisenstraße 3
80335 München / DE
[2023/17]
Application number, filing date22197284.726.06.2018
[2023/17]
Priority number, dateUS201762525131P26.06.2017         Original published format: US 201762525131 P
US201862641095P09.03.2018         Original published format: US 201862641095 P
[2023/17]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP4169539
Date:26.04.2023
Language:EN
[2023/17]
Search report(s)(Supplementary) European search report - dispatched on:EP07.03.2023
ClassificationIPC:A61L27/20, A61L27/50, A61L27/52, A61L27/22, A61L27/26
[2023/17]
CPC:
A61L27/52 (EP,IL,KR,US); A61L27/20 (EP,IL,KR,US); A61L27/26 (EP,IL,KR,US);
A61L27/227 (EP,IL,KR,US); A61L27/54 (KR); C08L5/08 (IL,KR);
C08L89/00 (IL); A61L2300/402 (EP,IL,KR,US); A61L2400/06 (EP,IL,KR,US);
A61L2430/34 (EP,IL,KR,US) (-)
C-Set:
A61L27/20, C08L5/08 (EP);
A61L27/227, C08L89/00 (EP);
A61L27/26, C08L5/08, C08L89/00 (EP)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2023/48]
Former [2023/17]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
Validation statesMANot yet paid
TitleGerman:GEWEBEFÜLLSTOFFE AUF BASIS VON SEIDENHYALURONSÄURE UND VERFAHREN ZUR VERWENDUNG DAVON[2023/17]
English:SILK-HYALURONIC ACID BASED TISSUE FILLERS AND METHODS OF USING THE SAME[2023/17]
French:CHARGES DE TISSU À BASE DE SOIE-ACIDE HYALURONIQUE ET LEURS PROCÉDÉS D'UTILISATION[2023/17]
Examination procedure26.10.2023Amendment by applicant (claims and/or description)
26.10.2023Examination requested  [2023/48]
26.10.2023Date on which the examining division has become responsible
10.04.2024Despatch of a communication from the examining division (Time limit: M02)
21.05.2024Reply to a communication from the examining division
14.08.2024Communication of intention to grant the patent
Parent application(s)   TooltipEP18823073.4  / EP3645063
Fees paidRenewal fee
11.01.2023Renewal fee patent year 03
11.01.2023Renewal fee patent year 04
11.01.2023Renewal fee patent year 05
27.06.2023Renewal fee patent year 06
27.06.2024Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]CN102836465  ;
 [XI]US2011189292  (LEBRETON PIERRE F [FR], et al);
 [A]WO2013040242  (ALLERGAN INC [US], et al);
 [A]WO2014055895  (ALLERGAN INC [US]);
 [AD]US2015094269  (ALTMAN GREGORY H [US], et al);
 [A]US2017136145  (LIU FUTIAN [US], et al);
 [XP]WO2018039496  (ALLERGAN INC [US]);
by applicantUS4355023
 US4657853
 US4676980
 US4925921
 US4970156
 US2006105022
 US8288347
 US8450475
 US2015093340
 US2015094269
 US9187538
 US2016022560
 US2016022561
 US2016022562
 US2016022563
 US2016193130
 US2016222579
 US2016281294
 US9511012
 US9517191
 US9522107
 US9522108
 US2016376382
 US9545369
 US2017315828
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.